Urica Therapeutics

Phase 3

Cambridge, United StatesFounded 2021uricatherapeutics.com

Urica Therapeutics is developing novel therapies for hyperuricemia and related metabolic disorders.

Market Cap

Private

Pipeline

—

Patents

—

Publications

—

Private Company

Total funding raised: $2.3M

Urica Therapeutics is developing novel therapies for hyperuricemia and related metabolic disorders.

Small Molecules

Total raised:$2.3M

Grant$500KNational Institutes of HealthAug 15, 2023

Seed$1.8MUndisclosedApr 15, 2022